GlassScriptPhysician profile
Dana Pizarek
NPI 1255003984
$3,821.44
in general payments reported to CMS, 2019-2025
32 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,504 · 2024: $1,150 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,728 · Debt Forgiveness: $93.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,728.38 |
| Debt Forgiveness | $93.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $467.25 | 2023-2025 | Verquvo, Winrevair, Capvaxive |
| Novartis Pharmaceuticals Corporation | $437.49 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.50 | 2023-2025 | Jardiance |
| Kestra Medical Technology Services, INC. | $278.90 | 2023-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $265.53 | 2023-2025 | Opsumit, Uptravi |
| Amgen INC. | $252.72 | 2023-2025 | Repatha, Repatha |
| Abbott Laboratories | $229.54 | 2023-2025 | Cardiomems, Aveir, Jot Dx |
| Pfizer INC. | $186.68 | 2023-2025 | |
| Edwards Lifesciences Corporation | $164.85 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Janssen Pharmaceuticals, INC | $139.37 | 2023-2024 | Xarelto |
| Baxter Healthcare | $124.50 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $119.12 | 2023-2024 | Inpefa |
| Atricure, INC. | $112.70 | 2024 | |
| Alnylam Pharmaceuticals INC. | $102.87 | 2023-2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $62.21 | 2023 | Arcalyst |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $56.39 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $53.63 | 2024-2025 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.09 | 2023-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $49.21 | 2023-2024 | Brilinta |
| Kiniksa Pharmaceuticals International, Plc | $43.47 | 2024 | Arcalyst |
| Nevro Corp. | $42.47 | 2023 | Senza |
| Sanofi-Aventis U.S. LLC | $38.11 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.00 | 2025 | |
| Daiichi Sankyo INC. | $26.33 | 2023 | Injectafer |
| Inari Medical, INC. | $24.37 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $22.88 | 2024 | Ozempic |
| Bard Peripheral Vascular, INC. | $21.53 | 2023 | Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $19.48 | 2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $17.34 | 2025 | Camzyos |
| Irhythm Technologies, INC. | $15.28 | 2023 | Zio Xt Patch |
| Inspire Medical Systems, INC. | $13.77 | 2025 | Inspire |
| Scpharmaceuticals INC. | $12.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Pizarek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.